---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038408"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:20:35.410653+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience to merge with NAYA Biosciences in all-stock deal; NAYA shareholders to own 88%

## Summary
- NAYA shareholders receive 7.33333 INVO shares per NAYA share, totaling ~18.15M shares.
- Combined company to operate as NAYA Biosciences; Dr. Daniel Teper named Chairman & CEO.
- Merger values INVO at $12.4M and NAYA at $90.8M; closing conditions include $5M+ interim PIPE and $5.00/share offering.
- Transaction unanimously approved by both boards, expected to close in Q4 2023.

## SEC filing metadata
- accession: 0001493152-23-038408
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/0001493152-23-038408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038408
- JSON: https://secwatch.observer/filing/0001493152-23-038408.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038408.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. entered into Agreement and Plan of Merger with NAYA Biosciences, Inc. (effective 2023-10-22).
  - Action: entry
  - Agreement: merger
  - Counterparty: NAYA Biosciences, Inc.
  - Effective: 2023-10-22
  source text: On October 22, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”), INVO Merger Sub Inc., a wholly owned subsidiary of the Company and a Delaware corporation (“ Merger Sub ”), and NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”), entered into an Agreement and Plan of Merger, as amended on October 25, 2023 (collectively, the “ Merger Agreement ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/0001493152-23-038408-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.